75 related articles for article (PubMed ID: 38693538)
1. Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare Occurrence.
Ollila TA; Kishkovich TP; Olszewski AJ; Patel NR; Jackson C; Roussel B; Niroula R; Treaba DO
R I Med J (2013); 2023 Mar; 106(2):8-12. PubMed ID: 36848533
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract][Full Text] [Related]
3. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract][Full Text] [Related]
4. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract][Full Text] [Related]
5.
Nayyar N; White MD; Gill CM; Lastrapes M; Bertalan M; Kaplan A; D'Andrea MR; Bihun I; Kaneb A; Dietrich J; Ferry JA; Martinez-Lage M; Giobbie-Hurder A; Borger DR; Rodriguez FJ; Frosch MP; Batchelor E; Hoang K; Kuter B; Fortin S; Holdhoff M; Cahill DP; Carter S; Brastianos PK; Batchelor TT
Blood Adv; 2019 Feb; 3(3):375-383. PubMed ID: 30723112
[TBL] [Abstract][Full Text] [Related]
6. Targetable genetic features of primary testicular and primary central nervous system lymphomas.
Chapuy B; Roemer MG; Stewart C; Tan Y; Abo RP; Zhang L; Dunford AJ; Meredith DM; Thorner AR; Jordanova ES; Liu G; Feuerhake F; Ducar MD; Illerhaus G; Gusenleitner D; Linden EA; Sun HH; Homer H; Aono M; Pinkus GS; Ligon AH; Ligon KL; Ferry JA; Freeman GJ; van Hummelen P; Golub TR; Getz G; Rodig SJ; de Jong D; Monti S; Shipp MA
Blood; 2016 Feb; 127(7):869-81. PubMed ID: 26702065
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses.
Oishi N; Kondo T; Nakazawa T; Mochizuki K; Tanioka F; Oyama T; Yamamoto T; Iizuka J; Tanabe K; Shibata N; Kirito K; Katoh R
Pathol Int; 2015 Oct; 65(10):528-35. PubMed ID: 26388135
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs: A new frontier in benzene-mediated toxicity.
Sanjari Nia AH; Reyhani Ardabili M; Sheikhvand M; Bagheri-Mohammadi S; Niknejad H; Rasoulzadeh H; Movafagh A; Kharazi Neghad S; Baniasadi M; Ashrafi Asgarabad A; Hosseini Neiresi SM; Aghaei-Zarch SM
Toxicology; 2023 Dec; 500():153660. PubMed ID: 37924934
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.
Huang C; Azizi P; Vazirzadeh M; Aghaei-Zarch SM; Aghaei-Zarch F; Ghanavi J; Farnia P
J Transl Med; 2023 Sep; 21(1):621. PubMed ID: 37705098
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer.
Pordel S; Khorrami M; Saadatpour F; Rezaee D; Cho WC; Jahani S; Aghaei-Zarch SM; Hashemi E; Najafi S
Pathol Res Pract; 2023 Sep; 249():154729. PubMed ID: 37639952
[TBL] [Abstract][Full Text] [Related]
11. microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance.
Fattahi M; Shahrabi S; Saadatpour F; Rezaee D; Beyglu Z; Delavari S; Amrolahi A; Ahmadi S; Bagheri-Mohammadi S; Noori E; Majidpoor J; Nouri S; Aghaei-Zarch SM; Falahi S; Najafi S; Le BN
Int J Biol Macromol; 2023 Oct; 250():125863. PubMed ID: 37467828
[TBL] [Abstract][Full Text] [Related]
12. P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas.
Vij M; Cho BB; Yokoda RT; Rashidipour O; Umphlett M; Richardson TE; Tsankova NM
Acta Neuropathol Commun; 2023 May; 11(1):73. PubMed ID: 37138345
[TBL] [Abstract][Full Text] [Related]
13. Drugging p53 in cancer: one protein, many targets.
Hassin O; Oren M
Nat Rev Drug Discov; 2023 Feb; 22(2):127-144. PubMed ID: 36216888
[TBL] [Abstract][Full Text] [Related]
14. Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations.
Minderman M; Amir A; Kraan W; Schilder-Tol EJM; Oud MECM; Scheepstra CG; Noorduyn AL; Kluin PM; Kersten MJ; Spaargaren M; Pals ST
Blood; 2021 Sep; 138(13):1194-1197. PubMed ID: 34125179
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
